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INTRODUCTION
 Breast cancer is the most common form 
of cancer present in women worldwide (Desantis, 
et al., 2014). Among all breast cancer types, 
triple-negative breast cancer (TNBC) is the most 
aggressive, difficult to treat and more likely to 
spread in diagnosed patients. Women with TNBC 
have poor prognosis with few treatment options, 
therefore, new therapeutic agents for this aggressive 
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Abstract
  
 Curcumin has been reported with an in vitro the cytotoxic effect on several human 
cancer cells. However, reports on the mode of action and detail mechanism of curcumin 
in breast cancer disease are limited. Hence, curcumin’s effect on the human breast cancer 
cell line MCF-7 and MDA-MB-468 was investigated. The MCF-7 and MDA-MB-468 breast cancer 
cells line were given curcumin in several doses. The anti-proliferation activity of curcumin 
was determined using the MTS cell viability test and caspase-3 activity was used to detect 
apoptosis using flowcytometry. The expression of Ras-association domain family 1 isoform A 
(RASSF1A) and Bax protein in cells was evaluated by  ELISA  analysis.  Kruskal-Wallis followed 
by the Mann-Whitney test and the Spearman correlation tests were used to asses correlation 
among RASSF1A, Bax, and caspase-3. Cytotoxicity of curcumin on MCF-7 was lower than that 
of MDA-MB-468 (75.73 μg/mL and 380.79 µg/mL). The concentration of curcumin at 80 μg/mL 
induced apoptosis mainly through the intrinsic pathway by caspase-3 activation. Curcumin also 
showed an anti-proliferative activity as shown by the increase of RASSF1A and Bax protein. 
Curcumin mediates anti-proliferative and apoptotic effect through the activation of RASSF1A 
and Bax. Our research data adds information about the role of curcumin in epigenetic events 
through RASSF1A protein.
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tumor are critically needed (Ismail-Khan & Bui, 
2010; Foulkes WD & Smith IE, 2010).
 Previous research found that flavonoids were 
capable to inhibit cancer cell proliferation and delay 
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tumour progression via epigenetic modification and 
by regulating apoptosis related signaling pathways 
such as Ras association (RalGDS/AF-6) domain 
family member 1 isoform (RASSF1A) pathways 
(Cao, et al., 2018). Curcumin is one of the possible 
candidates as anti-breast cancer agents through 
epigenetic pathway (Teiten, et al., 2013). The 
mechanism of inhibition by curcumin on cancer 
cell growth has been studied on various cancer cells 
lines (Moghtaderi, et al., 2017; Tomeh, et al., 2019; 
Hasima & Aggarwal, 2012; Zhou, et al., 2017) 
and thought that the mechanism is done through 
modulation of various biological activities including 
the activation epigenetic pathways (Koohpar, et al., 
2015).  
 In most breast cancer cases, the expression 
level of estrogen receptor α (ERα) is directly 
proportional to tumor growth. Therefore, the MCF-
7 cell model has been examined extensively to 
determine the mechanism of estrogen-stimulated 
growth in tumor (Holliday & Speirs, 2011; Ford, 
et al., 2011; Subik, et al., 2010). On the other hand, 
MDA-MB-468 (estrogen-receptor negative) cells 
that are aggressive and invasive TNBC cells are 
known to be resistant to several anti-cancer agents 
(Ismail-Khan & Bui, 2010; Holliday & Speirs, 
2011; Ford, et al., 2011; Subik, et al., 2010). Many 
work of literatures reported that curcumin can 
induce apoptosis in breast cancer cells that have 
ER-positive and triple-negative (Lv, et al., 2014; 
Hu, et al., 2018; Huang, et al., 2017; Liu, et al., 
2017).  
 The present study was aimed to investigate 
the cytotoxic effect and apoptosis induction of 




 MCF-7 and MDA-MB-468 breast cancer 
cell lines were purchased from ATCC (Manassas, 
VA, USA). Dubelco’s minimum essential medium 
(DMEM) (Gibco, New York, USA) supplemented 
with 10% fetal bovine serum (Biowest, Riverside, 
USA), with 5% of the amphotericin, and 5%  of 
the penicillin-streptomycin (Biosciences, San 
Jose, USA). Curcumin was purchased from Sigma 
Chemical Co. (St. Louis, MO, USA). The MTS kit 
was obtained from the Promega (Madison, USA). 
The RASSF1A kit was obtained from MyBiosource 
and Bax was obtained from Abcam. The caspase-3 
activity was determined using PE-conjugated 
monoclonal active caspase-3 antibody apoptosis kit 
(BD Pharmingen, Heidelberg, Germany).
Cell Culture
 MCF-7 and MDA-MB-468 cells were 
routinely cultured in tissue flask containing DMEM 
with 10% FBS, 5% penicillin/streptomycin, and 5% 
amphotericin at 370C in a humidified atmosphere 
with 5% CO2. To determine the effects of curcumin 
on cell proliferation, cells from stock plates were 
suspended by treatment with 0.25% trypsin, 
buffered with 0.2% EDTA (pH 7.3) and counted 
using a hemocytometer. Cells were adjusted to a 
density of 1x106 cells/well to the required volume 
of plating medium supplemented with 10% PBS 
dan adds curcumin dissolved in DMSO (Klawitter, 
et al., 2012).
Proliferation Study
 The breast cancer cells were seeded 
into 96-well plates at a density of 5,000 cells 
per well in triplicates and were treated with 1, 
50, 100, 150, 200, 250, 300, 350, 400 µg/mL 
concentrations of curcumin for 48 h (according 
to the Promega datasheet). DMSO (0.1%) was 
added to the control wells followed by incubation 
at 37°C for 2 h after addition of 20 mg/mL 3-(4,5 
dimethylthiazol-2-yl)-5(3-carboximetoniphenol)-
2-(4-sulphodenil)-2H-tetrazolium) (MTS) to 
each well. Absorbance was measured on optical 
density at 490 nm. The IC50 was developed by an 
inhibition curve and recorded as the mean±standard 
deviation of three independent experiments.
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Evaluation of RASSF1A and Bax
 The test kits were sandwich enzyme 
immunoassay. The optical density (OD) was 
determined using a microplate reader set at 450 nm. 
The concentration of protein in the samples was 
determined by comparing the OD of the samples to 
the standard curve.
Determination of Caspase-3 Activity
 The caspase-3 activity was determined using 
flowcytometry according to the manufacturer’s 
instructions. Cisplatin was used as the positive 
control and the untreated sample was used as the 
negative control. Fold-increase in caspase activity 
was determined by comparing the results of treated 
samples with the level of the untreated control.
Statistical analysis. All statistical analyses were 
performed using the SPSS 20.0 statistical software 
for Windows. Statistical significance was determined 
using the Kruskal-Wallis test followed by the 
Mann-Whitney Posthoc for multiple comparisons. 
Statistical significance was set at p<0.05.
RESULT
Curcumin Inhibited Proliferation on MCF-7 
and MDA-MB-468 Cells
 The cell proliferation was inhibited 
by curcumin in a dose-dependent manner. The 
inhibitory concentration 50 (IC50) values for the 
MCF-7 cells were detected at 75.73 µg/mL and 
the MDA-MB-468 cells were detected at 380.79 
µg/mL. These results indicated that curcumin has 
potent anti-proliferative effect in breast cancer cells. 
Curcumin Induces Apoptosis on MCF-7 and 
MDA-MB-468 cells
 Our results showed that curcumin in a dose-
dependent manner induced apoptosis. As shown 
in Figure 1, the percentage of caspase-3 with a 
concentration of curcumin 70 µg/mL increased from 
1.12% to 71.94%, from 0.48% to 76.69% in MCF-
7 and MDA-MB-468 cells, respectively. Under the 
treatment with a concentration of curcumin 80 µg/
mL, the caspase-3 increased to 94.75% and 93.55% 
in MCF-7 and MDA-MB-468 cells. 
Figure 1. The regulatory effect of curcumin on 
apoptosis in (A) MCF-7 and (B) MDA-MB-468 
cells. The cells were treated with a specific 
concentration of curcumin for 24  h. Flowcy-
tometry assay of curcumin-induced apoptosis 
cells for 24  h (in %, Y axis); untreated, 70 µg/
mL, and 80 µg/mL (dose, X axis).  Curcumin in-
duced apoptosis cell on MCF-7 and MDA-MB-468 
cells in a dose-dependent manner. 
Curcumin Up-regulated the Protein Expres-
sion of RASSF1A on MCF-7 and MDA-MB-468 
cells 
 To investigate whether suppression of 
proliferation of breast cancer cells by curcumin 
is due to the downregulation of molecules in-
volved in cell proliferation, we tested the protein 
levels of RASSF1A in cells. As shown in Figure 
2, at  the  previously  demonstrated  pharmaco-
logical effective (anti-proliferation and apoptosis) 
concentrations, curcumin could significantly in-
creased the protein levels of RASSF1A on MCF-
7 and MDA-MB-468 cells. We found that cur-
cumin treatment increases the protein expression of 
RASSF1A in a dose-dependent manner. Compared 
with MDA-MB-468 cells, the MCF-7 cells ex-
pressed an increased level of protein in RASSF1A.
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Curcumin Up-regulated the Protein of Bax 
on MCF-7 and MDA-MB-468
 We further investigated the mechanisms 
underlying curcumin-induced apoptosis in breast 
cancer cells. As shown in Figure 2, Bax levels were 
significantly up-regulated by curcumin in both cells 
in a dose-dependent manner.
DISCUSSION
 Curcumin is a group of flavonoids that 
shows great potential as cancer chemopreventive 
agents in cell culture studies and it is known to 
have an anti-proliferation flavonoid. To be a potent 
anti-cancer in a biological system, a flavone should 
contain methoxy groups that metabolize faster to 
the conversion of flavonoid products (Sharma, et 
al., 2005).  In the previous study of Pushpalatha, 
et al., IC50 curcumin was reported on MCF-7 cells 
using the 72 h incubation MTT method of 21.29 
µg/mL. In the Koohpar, et al. study it was reported 
that IC50 curcumin on MCF-7 cells using the MTT 
method at 24 h incubation was 79.58 µg/mL and 
the results decreased after 48 h incubation (53.18 
µg/mL) and 72 h (30.78) µg/mL). In the study of 
Hu, et al. It was reported IC50 curcumin on MCF-
7 cells using the 72 h MTT incubation method of 
1.32 μM (conversion of 0.49 µg/mL) and on MDA-
MB-468 cells of 18.61 µM (conversion of 6.85 µg/
mL). It is difficult to obtain literature that states 
that research uses MTS. In this study, the IC50 of 
curcumin on MDA-MB-468 (triple-negative) cells 
was higher than that of MCF-7 cells (75.73 µg/
mL and 380.79 µg/mL), indicating that the MDA-
MB-468 cells were less sensitive than MCF-7 
cells. The differences in the results of the average 
inhibition of curcumin lie on individual cell factors. 
Martin, et al. reported that gene modification or the 
microenvironment often resulted in changes in cell 
division (Martin, et al., 2009). The IC50 of curcumin 
on MDA-MB-468 results are consistent with the 
nature of triple-negative cancer cells that have an 
intermediate response to chemotherapy (Holliday 
and Speirs, 2011).
 It is generally believed that the balance 
between proliferation and apoptosis influences the 
response of tumors to cytotoxic treatment. Apoptosis 
is considered as a significant form of cancer cell 
death after treatment with the cytotoxic drug and 
has been recognized as a standard strategy for the 
selection of anti-cancer drugs (Yew, et al., 2008). 
The caspase family of cysteine proteases plays a 
 
Figure 2. Curcumin up-regulated RASSF1A and Bax of protein on MCF-7 and MDA-MB-468 cells. (a. Statis-
tical significance (p< 0.05) compared to the untreated for the respective time point, b. statistical signifi-
cance (p<0.05) compared to the treated group for 24  h. (concentration, Y axis; dose, X axis)
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key role in apoptosis. Caspase-3 is a key protease 
that is activated during the early stages of apoptosis 
and responsible for core apoptosis. Caspase-3 
deficiency and down-regulation have been reported 
to be associated with breast carcinogenesis 
(McIlwain, et al., 2013; Ponder,  et al., 2019; Larsen 
& Sørensen, 2017). MCF-7, a breast cancer-derived 
cell line, is deficient of caspase-3 and relatively 
insensitive to many chemotherapy. Reconstitution 
of caspase-3 sensitizes MCF-7 breast cancer cells 
to doxorubicin- and etoposide-induced apoptosis 
(Yang, et al., 2001; Wang, et al., 2016). The reports 
study have demonstrated the synergistic effects of 
paclitaxel in combination and alone with curcumin 
induced caspase-3 (Calaf, et al., 2018). In another 
research report that the administration of curcumin 
and neoadjuvant chemotherapy in patients with 
triple negative breast cancer increases caspase-3 
levels (Siregar, et al., 2017). This indicates that 
increased activity of caspase-3 after treatment with 
curcumin may play an important role in cancer 
prevention and treatment.  
 Although the IC50 value of curcumin 
on MDA-MB-468 was higher than MCF-7, the 
administration of curcumin around MCF-7 of IC50 
concentrations affected the increase in RASSF1A 
protein in MDA-MB-468, yet the effect was 
smaller than that of MCF-7. This result showed the 
potential anti-tumor effect of curcumin which was 
worthwhile to be investigated. A previous study 
reported that curcumin inhibits the activity of M. 
SssI (bacterial DNA methyltransferase) which is 
a DNMT analog, through inhibition of catalytic 
thiolate C1226 DNA methyltransferase 1 (DNMT1) 
(Parashar, et al., 2012). The α-carbon bis-α, 
β-unsaturated ketone overlaps the C-6 atom of the 
cytosine ring in the catalytic space through the 
C-3 portion of keto curcumin. The covalent bond 
will inhibit DNMT1 activity without joining DNA 
(Liu, et al., 2009). Curcumin causes reactivation 
of RASSF1A expression in MCF-7 cells by 
inhibiting DNMT1 activity and in vivo reactivation 
of RASSF1A in MCF-7 cells implanted in mice 
(Liu, et al., 2012). Curcumin also increases the 
RASSF1A protein by increasing mRNA in MCF-
7 and MDA-MB-468 (Du, et al., 2012). Increased 
RASSF1A protein levels in this study indicate that 
there is a possibility of epigenetic processes in the 
form of DNA methylation. Hypermethylation of 
RASSF1A causes suppression of RASSF1A gene 
function so that it will decrease RASSF1A protein. 
In contrast to genetic mutation, DNA methylation 
is susceptible to change and reversible (Goel & 
Aggarwal, 2010; Basnet & Skalko-Basnet, 2011). 
Hence, these results suggest that curcumin is an 
excellent agent that could be involved in DNA 
methylation changes and be useful for chemotherapy 
and chemoprevention. Reactivation of RASSF1A 
by curcumin will result in the restoration of their 
biological functions. Further research is needed to 
examine DNA methylation.  
 The other key cellular process that may be 
mediated by RASSF1A the regulation of apoptosis. 
The intrinsic pathway of apoptosis involves the 
activation of the proapoptotic members of the Bcl-
2 family using its function through mitochondria. 
Curcumin induces the release of cytochrome-c 
from mitochondria, causing activation of caspase 3 
and the breakdown of Poly ADP ribose polymerase 
(PARP), which is a feature of caspase-dependent 
apoptosis (Wong, 2011). A previous study reported 
that RASSF1A can regulate Bax activity through 
direct binding to the apoptotic modulator (MOAP1), 
a protein that binds to Bax (Law, et al., 2015). Our 
results demonstrated that the curcumin increase Bax 
protein levels which resulted in increase caspase-3 
activity followed by apoptosis in MDA-MB-468 
cells.
 Our study showed that there was no 
correlation between RASSF1A protein levels and 
Bax protein levels in MCF-7 cells. Apoptosis can 
be induced by Mammalian sterile 20-like kinase-1 
(MST1) without going through Bax. A previous 
study reported that ROS causes phosphorylation 
of MST1/2, causing thioredoxin to be released and 
binds to MST1 through the Salvador-RASSF1A-
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Hippo (SARAH) domain. Furthermore, thioredoxin 
activates endogenous MST1/2 kinase, resulting 
in the division of MST1/2 fragments and binds 
to caspase-3 (Chae, et al., 2012). These results 
indicate that RASSF1A can increase apoptosis 
through the Bax and MST1 pathways in MCF-7 
cells. We also find a correlation between RASSF1A 
protein levels and caspase-3 in MDA-MB-468 
cells. Apoptosis in triple-negative breast cancer 
cells can occur through various pathways. Hu, et al. 
(Hu, et al., 2018) reported that curcumin induces 
apoptosis in triple-negative breast cancer cells by 
inhibiting the activity of Akt/PKB (protein kinase 
B) and decreasing Bcl-2.
CONCLUSION
 This study showed that the administration 
of curcumin treatment to MCF-7 and MDA-
MB-468 cells efficiently enhances the suppression 
of the growth of the breast cancer cells in vitro 
through reactivation of RASSF1A, upregulation of 
Bax and induction of apoptosis.
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